Advances in the prevention and treatment of cardiovascular disease

Myron L. Weisfeldt, Susan J. Zieman

Research output: Contribution to journalReview articlepeer-review

48 Scopus citations


Over the past thirty-five years, U.S. age-adjusted mortality from cardiovascular disease declined 50 percent. This marked reduction reflects advances in the prevention, diagnosis, and treatment of common cardiovascular conditions. Pharmaceutical agents play a major role in prevention of atherosclerosis and its consequences: heart attack, stroke, and heart failure. Additionally, novel device-based therapies contribute to the decline in cardiac morbidity and mortality. Whereas innovative strategies based on accurate imaging of the heart and blood vessels are implemented widely now, hope exists that lifestyle changes, early risk-factor screening, and more efficacious drugs will strikingly reduce cardiovascular disease in the future.

Original languageEnglish (US)
Pages (from-to)25-37
Number of pages13
JournalHealth Affairs
Issue number1
StatePublished - Jan 2007
Externally publishedYes

ASJC Scopus subject areas

  • Health Policy


Dive into the research topics of 'Advances in the prevention and treatment of cardiovascular disease'. Together they form a unique fingerprint.

Cite this